{"entity":{"type":"insider","cik":"0001284934","url":"/insider/0001284934","json_url":"/insider/0001284934.json","name":"VAN VOORHEES SETH","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":9,"first":"2006-02-21","last":"2022-12-19","span_basis":"filed_date"},"name_variants":[{"name":"VAN VOORHEES SETH","source":"filing","n_filings":9,"first_seen":"2006-02-21","last_seen":"2022-12-19"}],"transactions":[{"id":6868726,"accession":"0001415889-22-012652","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-012652","line_url":"/filing/0001415889-22-012652#line-1","is_derivative":false,"issuer_cik":"0001284934","issuer_name":"NRX Pharmaceuticals, Inc.","issuer_ticker":"NRXP","issuer_name_source":null,"issuer_url":"/issuer/0001284934","owner_cik":"0001284934","owner_name":"VAN VOORHEES SETH","owner_display_name":"VAN VOORHEES SETH","owner_url":"/insider/0001284934","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":33000.0,"total_display":"33,000.00","total_whole":"33,000","shares_owned_after":46337.0,"shares_owned_after_display":"46,337","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-19","scope":"insider"},{"id":9287199,"accession":"0001415889-22-012650","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-012650","line_url":"/filing/0001415889-22-012650","is_derivative":false,"issuer_cik":"0001284934","issuer_name":"NRX Pharmaceuticals, Inc.","issuer_ticker":"NRXP","issuer_name_source":null,"issuer_url":"/issuer/0001284934","owner_cik":"0001284934","owner_name":"VAN VOORHEES SETH","owner_display_name":"VAN VOORHEES SETH","owner_url":"/insider/0001284934","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16337.0,"shares_display":"16,337","price_per_share":1.1149678643569811,"price_display":"1.11","price_state":"stated","total_value":18215.23,"total_display":"18,215.23","total_whole":"18,215","shares_owned_after":9316.0,"shares_owned_after_display":"9,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-25","filed_date":"2022-12-19","scope":"insider","n_lines":3},{"id":6506120,"accession":"0001415889-22-011778","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-22-011778","line_url":"/filing/0001415889-22-011778","is_derivative":false,"issuer_cik":"0001284934","issuer_name":"NRX Pharmaceuticals, Inc.","issuer_ticker":"NRXP","issuer_name_source":null,"issuer_url":"/issuer/0001284934","owner_cik":"0001284934","owner_name":"VAN VOORHEES SETH","owner_display_name":"VAN VOORHEES SETH","owner_url":"/insider/0001284934","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16337.0,"shares_display":"16,337","price_per_share":1.1149678643569811,"price_display":"1.11","price_state":"stated","total_value":18215.23,"total_display":"18,215.23","total_whole":"18,215","shares_owned_after":8716.0,"shares_owned_after_display":"8,716","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-25","filed_date":"2022-11-28","scope":"insider","n_lines":3},{"id":5354924,"accession":"0001140361-21-021491","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-21-021491","line_url":"/filing/0001140361-21-021491#line-1","is_derivative":false,"issuer_cik":"0001284934","issuer_name":"PDS Biotechnology Corp","issuer_ticker":"PDSB","issuer_name_source":null,"issuer_url":"/issuer/0001284934","owner_cik":"0001284934","owner_name":"VAN VOORHEES SETH","owner_display_name":"VAN VOORHEES SETH","owner_url":"/insider/0001284934","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17647.0,"shares_display":"17,647","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":149999.5,"total_display":"149,999.50","total_whole":"150,000","shares_owned_after":17647.0,"shares_owned_after_display":"17,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-17","scope":"insider"},{"id":4678989,"accession":"0001493152-17-010518","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-17-010518","line_url":"/filing/0001493152-17-010518#line-1","is_derivative":false,"issuer_cik":"0000793524","issuer_name":"RESEARCH FRONTIERS INC","issuer_ticker":"REFR","issuer_name_source":null,"issuer_url":"/issuer/0000793524","owner_cik":"0001284934","owner_name":"VAN VOORHEES SETH","owner_display_name":"VAN VOORHEES SETH","owner_url":"/insider/0001284934","role":"Officer (CFO & VP-Buisness Develpoment)","role_mark":"O","role_mark_label":"Officer (CFO & VP-Buisness Develpoment)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & VP-Buisness Develpoment","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.15,"price_display":"1.15","price_state":"stated","total_value":4600.0,"total_display":"4,600.00","total_whole":"4,600","shares_owned_after":138900.0,"shares_owned_after_display":"138,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-12","filed_date":"2017-09-13","scope":"insider"},{"id":7067653,"accession":"0001206774-14-001992","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001206774-14-001992","line_url":"/filing/0001206774-14-001992#line-1","is_derivative":false,"issuer_cik":"0000793524","issuer_name":"RESEARCH FRONTIERS INC","issuer_ticker":"REFR","issuer_name_source":null,"issuer_url":"/issuer/0000793524","owner_cik":"0001284934","owner_name":"VAN VOORHEES SETH","owner_display_name":"VAN VOORHEES SETH","owner_url":"/insider/0001284934","role":"Officer (CFO & VP-Business Development)","role_mark":"O","role_mark_label":"Officer (CFO & VP-Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & VP-Business Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":10900.0,"total_display":"10,900.00","total_whole":"10,900","shares_owned_after":134900.0,"shares_owned_after_display":"134,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-19","filed_date":"2014-06-19","scope":"insider"},{"id":9020010,"accession":"0000793524-11-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000793524-11-000013","line_url":"/filing/0000793524-11-000013","is_derivative":false,"issuer_cik":"0000793524","issuer_name":"RESEARCH FRONTIERS INC","issuer_ticker":"REFR","issuer_name_source":null,"issuer_url":"/issuer/0000793524","owner_cik":"0001284934","owner_name":"VAN VOORHEES SETH","owner_display_name":"VAN VOORHEES SETH","owner_url":"/insider/0001284934","role":"Officer (VicePresident-Business Dev/CFO)","role_mark":"O","role_mark_label":"Officer (VicePresident-Business Dev/CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VicePresident-Business Dev/CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24000.0,"shares_display":"24,000","price_per_share":8.65,"price_display":"8.65","price_state":"stated","total_value":207600.0,"total_display":"207,600.00","total_whole":"207,600","shares_owned_after":36000.0,"shares_owned_after_display":"36,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-10","filed_date":"2011-02-14","scope":"insider","n_lines":2},{"id":5511288,"accession":"0001209191-06-014996","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-014996","line_url":"/filing/0001209191-06-014996#line-1","is_derivative":false,"issuer_cik":"0000350832","issuer_name":"AMERICAN PACIFIC CORP","issuer_ticker":"APFC","issuer_name_source":null,"issuer_url":"/issuer/0000350832","owner_cik":"0001284934","owner_name":"VAN VOORHEES SETH","owner_display_name":"VAN VOORHEES SETH","owner_url":"/insider/0001284934","role":"Officer (VP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (VP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5893.0,"shares_display":"5,893","price_per_share":5.71,"price_display":"5.71","price_state":"stated","total_value":33649.03,"total_display":"33,649.03","total_whole":"33,649","shares_owned_after":5893.0,"shares_owned_after_display":"5,893","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-03-01","filed_date":"2006-03-03","scope":"insider"},{"id":3459747,"accession":"0001209191-06-012174","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-06-012174","line_url":"/filing/0001209191-06-012174","is_derivative":false,"issuer_cik":"0000350832","issuer_name":"AMERICAN PACIFIC CORP","issuer_ticker":"APFC","issuer_name_source":null,"issuer_url":"/issuer/0000350832","owner_cik":"0001284934","owner_name":"VAN VOORHEES SETH","owner_display_name":"VAN VOORHEES SETH","owner_url":"/insider/0001284934","role":"Officer (VP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (VP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":5.575191333333334,"price_display":"5.58","price_state":"stated","total_value":83627.87,"total_display":"83,627.87","total_whole":"83,628","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-02-17","filed_date":"2006-02-21","scope":"insider","n_lines":15}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":28,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001719406","name":"NRX Pharmaceuticals, Inc.","url":"/issuer/0001719406","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":3,"first_seen":"2022-11-28","last_seen":"2022-12-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001472091","name":"PDS Biotechnology Corp","url":"/issuer/0001472091","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2021-06-17","last_seen":"2021-06-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000793524","name":"RESEARCH FRONTIERS INC","url":"/issuer/0000793524","role":"Officer (CFO & VP-Buisness Develpoment)","n_filings":3,"first_seen":"2011-02-14","last_seen":"2017-09-13"},{"type":"issuer","type_label":"ISSUER","cik":"0000350832","name":"AMERICAN PACIFIC CORP","url":"/issuer/0000350832","role":"Officer (VP, CFO & Treasurer)","n_filings":2,"first_seen":"2006-02-21","last_seen":"2006-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001284934","retrieved_at":"2026-08-25T08:05:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}